- Home
- MMT vs ARCT Comparison
MMT vs ARCT Comparison
Compare MMT & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMT
- ARCT
- Stock Information
- Founded
- MMT 1987
- ARCT 2013
- Country
- MMT United States
- ARCT United States
- Employees
- MMT N/A
- ARCT N/A
- Industry
- MMT Trusts Except Educational Religious and Charitable
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- MMT Finance
- ARCT Health Care
- Exchange
- MMT Nasdaq
- ARCT Nasdaq
- Market Cap
- MMT 254.7M
- ARCT 298.3M
- IPO Year
- MMT N/A
- ARCT N/A
- Fundamental
- Price
- MMT $4.66
- ARCT $13.78
- Analyst Decision
- MMT
- ARCT Strong Buy
- Analyst Count
- MMT 0
- ARCT 8
- Target Price
- MMT N/A
- ARCT $52.83
- AVG Volume (30 Days)
- MMT 86.5K
- ARCT 474.9K
- Earning Date
- MMT 01-01-0001
- ARCT 08-04-2025
- Dividend Yield
- MMT 8.58%
- ARCT N/A
- EPS Growth
- MMT N/A
- ARCT N/A
- EPS
- MMT 0.30
- ARCT N/A
- Revenue
- MMT N/A
- ARCT $143,680,000.00
- Revenue This Year
- MMT N/A
- ARCT N/A
- Revenue Next Year
- MMT N/A
- ARCT $34.79
- P/E Ratio
- MMT $15.33
- ARCT N/A
- Revenue Growth
- MMT N/A
- ARCT 15.38
- 52 Week Low
- MMT $4.04
- ARCT $8.04
- 52 Week High
- MMT $4.70
- ARCT $25.88
- Technical
- Relative Strength Index (RSI)
- MMT 51.38
- ARCT 54.34
- Support Level
- MMT $4.53
- ARCT $13.10
- Resistance Level
- MMT $4.70
- ARCT $15.20
- Average True Range (ATR)
- MMT 0.03
- ARCT 1.02
- MACD
- MMT -0.00
- ARCT 0.07
- Stochastic Oscillator
- MMT 50.00
- ARCT 55.21
About MMT MFS Multimarket Income Trust
MFS Multimarket Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests a majority of its net assets in fixed-income securities, corporate bonds of the U.S and foreign issuers, U.S Government securities, foreign government securities, mortgage-backed and other asset-backed securities of U.S and foreign issuers, and debt instruments of issuers located in emerging market countries. The portfolio of investments comprises of different sector investments such as aerospace, airlines, automotive, chemicals, electronics, and others.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.